Standard dosage regimen for sitagliptin and metformin combination

Answer generated by Itaca · 5 sources · December 05, 2024

Original question

Standard dosage regimen for combination of sitagliptin and metformin

Summary

The combination of sitagliptin and metformin is commonly used to improve glycemic control in patients with type 2 diabetes mellitus. Here are the key points regarding the standard dosage regimen:

  • The dosage should be individualized based on the patient's current regimen, effectiveness, and tolerability.
  • The maximum recommended daily dose is 100 mg of sitagliptin and 2000 mg of metformin hydrochloride.

Indications and Initial Dosage

Patients Not Currently Treated with Metformin

  • The recommended starting dose is 50 mg of sitagliptin and 500 mg of metformin hydrochloride twice daily[1][2].

Patients Already Treated with Metformin

  • For patients not adequately controlled on metformin alone, the usual starting dose should provide sitagliptin dosed as 50 mg twice daily (100 mg total daily dose) plus the dose of metformin already being taken. For example, if a patient is taking 850 mg or 1000 mg of metformin twice daily, the starting dose of the combination could be 50 mg of sitagliptin and 1000 mg of metformin twice daily[3][4][2].

Dosage Forms and Administration

Immediate-Release Tablets

  • Initial dose for patients not receiving metformin: sitagliptin 50 mg/metformin 500 mg orally twice a day.
  • Initial dose for patients receiving metformin: sitagliptin 50 mg in combination with half the daily dose of metformin orally twice a day[1].

Extended-Release Tablets

  • Initial dose for patients not receiving metformin: sitagliptin 100 mg/metformin 1000 mg orally once a day.
  • Initial dose for patients receiving metformin: sitagliptin 100 mg in combination with the current daily metformin dose orally once a day[1].

Maximum Dosage

  • The maximum recommended daily dose is 100 mg of sitagliptin and 2000 mg of metformin hydrochloride[1][2].

Renal Dose Adjustments

  • For patients with mild renal impairment (GFR ≥ 60 mL/min), no dose adjustment is needed.
  • For patients with moderate renal impairment (GFR 30-59 mL/min), initiating therapy is not recommended, and dose reduction may be necessary.
  • For patients with severe renal impairment (GFR < 30 mL/min), the use of metformin is contraindicated, and sitagliptin should be limited to 25 mg/day if continued[4][1].

Special Considerations

  • When used in combination with a sulfonylurea or insulin, a lower dose of the sulfonylurea or insulin may be required to reduce the risk of hypoglycemia[3][4][2].
  • Patients should continue their recommended diet and exercise regimen while taking this medication[5].

Administration Instructions

  • The medication should be taken with meals to help reduce any stomach upset.
  • Extended-release tablets should be taken in the evening.
  • Patients should not crush, break, or chew the tablets[5].

Sources

  1. https://www.drugs.com/dosage/metformin-sitagliptin.html
  2. https://www.drugs.com/dosage/janumet.html
  3. https://www.ema.europa.eu/en/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf
  4. https://www.ema.europa.eu/en/documents/product-information/sitagliptin-metformin-hydrochloride-sun-epar-product-information_en.pdf
  5. https://www.mayoclinic.org/drugs-supplements/sitagliptin-and-metformin-oral-route/description/drg-20070903

AI-generated answer based on the cited sources. Check the sources before applying it.

Have a question about your own case? Itaca answers with sources in seconds.

Ask a question

More questions about Diabetes Mellitus, Type 2